VANCOUVER, British Columbia – Cannabix Technologies Inc., a pioneering developer of marijuana and alcohol breath-testing devices, has announced a significant marketing milestone. The company's Marijuana Breath Test (MBT) system will be featured on the cover of the 2026 product catalog from AlcoPro Inc., a leading U.S. supplier of professional drug and alcohol testing equipment.
Strategic Partnership and Market Reach
AlcoPro, based in Knoxville, Tennessee, has been serving customers since 1982 and is recognized as a trusted provider of testing instruments, kits, and supplies for employers, healthcare professionals, law enforcement, and substance abuse specialists. The 2026 catalog will be distributed to more than 85,000 businesses across the United States and internationally, including key segments such as law enforcement and corrections.
Cannabix and AlcoPro have been collaborating closely on pre-launch marketing activities for the MBT, primarily targeting the U.S. market. This partnership represents a strategic move to enhance the visibility and adoption of advanced breath-testing technologies in workplace safety and law enforcement applications.
Technical Innovation and Expertise
The Marijuana Breath Test system integrates Cannabix's proprietary Breath Collection Unit and Breath Cartridge technologies, which are designed to capture and preserve non-invasive breath samples for gold-standard LC-MS (liquid chromatography-mass spectrometry) analysis. This approach aims to provide accurate detection of recent marijuana use, specifically targeting delta-9 THC, the primary psychoactive component in cannabis.
To bolster its capabilities, Cannabix has formed a strategic partnership with Omega Laboratories Inc., a global leader in forensic drug testing with over 25 years of experience. Omega Laboratories brings world-class expertise, backed by multiple federal and international certifications, enhancing the reliability and innovation of Cannabix's drug detection solutions.
Industry Endorsement and Future Outlook
Brian Terry, Director of Business Development at AlcoPro, expressed enthusiasm about the growing relationship with Cannabix Technologies. He stated, "We are excited about our growing relationship with Cannabix Technologies, and the upcoming availability of the MBT to our clients. We're moving beyond traditional testing tools and leaning into advanced technologies that deliver the accuracy today's workplaces demand. As safety challenges shift, staying ahead with solutions that proactively reduce risk is essential to protecting employees."
This feature on AlcoPro's catalog cover underscores the increasing demand for sophisticated testing solutions in response to evolving safety regulations and the legalization of cannabis in various jurisdictions. Cannabix is also developing its Breath Logix Series of breath alcohol detection devices, catering to employers and other settings, further expanding its portfolio in the breathalyzer market.
The collaboration highlights a trend toward non-invasive, accurate testing methods that can help organizations maintain safety standards and comply with legal requirements. As workplaces and law enforcement agencies seek reliable tools to detect impairment, innovations like the MBT are poised to play a crucial role in modern drug testing protocols.
